Comparative alpha-1 adrenoceptor subtype selectivity and functional uroselectivity of alpha-1 adrenoceptor antagonists

Journal of Pharmacology and Experimental Therapeutics

Volumn 282, Issue 1, 1997, Pages 228-235

  Martin, D J ^a   Lluel, P ^a   Guillot, E ^a   Coste, A ^a   Jammes, D ^a   Angel, I ^a  

^a SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLURAPIDIL; ALFUZOSIN; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1A ADRENERGIC RECEPTOR; ALPHA 1B ADRENERGIC RECEPTOR; ALPHA 1D ADRENERGIC RECEPTOR; DOXAZOSIN; PHENYLEPHRINE; PRAZOSIN; RECEPTOR SUBTYPE; TAMSULOSIN; TERAZOSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SELECTIVITY; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; RAT; RECEPTOR AFFINITY; URETHRA PRESSURE;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HELA CELLS; HUMANS; MALE; RABBITS; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0030759115     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. 1-adrenoceptor subtypes mediate contraction in rabbit aorta and urethra. Eur. J. Pharmacol. 287: 153-161, 1995.
2. 1c-adrenoceptor: Studies in the isolated perftised kidney of rat. Br. J. Pharmacol. 115: 283-294, 1995.
3. BRUNE, M. E., KATWALA, S. P., MILICIC, I., HANCOCK, A. A. AND KERWIN, JR., J. F.: Simultaneous evaluation of the effects of alphal-adrenergic antagonists on vascular and prostatic smooth muscle in intact conscious dogs. J. Urol. 155: 332A, 1996.
4. 1A-Adrenoceptor subtype mediates contraction of the rat urethra. J. Auton. Pharmacol. 14: 375-381, 1994.
5. ERI, L. M. AND TVETER, K. J.: α-Blockade in the treatment of symptomatic benign prostatic hyperplasia. J. Urol. 154: 923-934, 1995.
6. 1-adrenoceptor classification. Eur. J. Pharmacol. 268: 141-149, 1994.
7. 1-adrenoceptors in human prostate: Implications for adrenoceptor classification. Eur. J. Pharmacol. 49: 209-215, 1996a.
8. 1A-adrenoceptor? Br. J. Pharmacol. 118: 29P, 1996b.
9. 1c subtype. Mol. Pharmacol. 45: 703-708, 1994.
10. HIEBLE, J. P., CAINE, M. AND ZALAZNIK, E.: In vitro characterization of the α-adrenoceptors in human prostate. Eur. J. Pharmacol. 107: 111-117, 1985.
11. JAMES, S., CHAPPLE, C. R., PHILLIPS, M. I. AND BURNSTOCK, G.: Autoradiographic analysis of alpha-adrenoceptors and muscarinic cholinergic receptors in hyperplasic human prostate. J. Urol. 142: 438-444, 1989.
12. JENKINSON, D. H.: How do we describe competitive antagonists: Three questions of usage. Trends Pharmacol. Sci. 12: 53-54, 1991.
13. JONLER, M., RIEHMAN, M. AND BRUSKEWITZ, R. C.: Benign prostatic hyperplasia: Current pharmacological treatment. Drugs 47: 66-81, 1994.
14. KAWABE, K.: Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia. Br. J. Urol. 76: 63-67, 1995.
15. KENNY, B. A., NAYLOR, A. M., CARTER, A. J., READ, A. M., GREENGRASS, P. M. AND WYLLIE, M. G.: Effect of alpha-1-adrenoceptor antagonists on prostatic pressure and blood pressure in the anaesthetised dog. Urology 44: 52-57, 1994.
16. 1 adrenoceptors: Binding, functional and in vivo studies. Br. J. Pharmacol. 118: 871-878, 1996.
17. KOBAYASHI, S., TANG, R., SHAPIRO, E. AND LEPOR, H.: Characterization and localization of prostatic alpha1 adrenoceptors using radioligand binding on slide-mounted tissue sections. J. Urol. 150: 2002-2006, 1993.
18. LEFÈVRE-BORG, F., LECHAIRE, J. AND O'CONNOR, S.: In vivo uroselectivity of alfuzosin compared to prazosin and terazosin. Br. J. Pharmacol. 106: 84P, 1992.
19. 1-adrenoceptor antagonist in the lower urinary tract. Br. J. Pharmacol. 109: 1282-1289, 1993.
20. 1c) adrenoceptor subtype. Br. J. Pharmacol. 1155: 781-786, 1995.
21. MARTIN, D., JAMMES, D. AND ANGEL, I.: Effects of Alfuzosin on urethral and blood pressures in conscious male rats. Life Sci. 57: PL387-PL391, 1995.
22. 1-adrenoceptor. Naunyn-Schmiederberg Arch. Pharmacol. 348: 385-395, 1993.
23. 1-adrenoceptor subtypes. Naunyn-Schmiedeberg Arch. Pharmacol. 350: 136-142, 1994.
24. 1-adrenoceptor subtypes in the human prostate: Functional and binding studies. Br. J. Urol. 74: 572-578, 1994.
25. PRICE, D. T., SCHWINN, D. A., LOMASNEY, J. W., ALLEN, L. F., CARON, M. G. AND LEFKOWITZ, R. J.: Identification, quantitation and localization of mRNA for three distinct alpha1 adrenergic subtypes in human prostate. J. Urol. 150: 546-551, 1993.
26. RAMAGE, A. G. AND WYLLIE, M. G.: A comparison of the effects of doxazosin and terazosin on the spontaneous sympathetic drive to the bladder and related organs in anaesthetized cats. Eur. J. Pharmacol. 294: 645-650, 1995.
27. SHIBASAKI, M., SUDOH, K., INAGAKI, O., UCHIDA, W. AND HONDA, K.: Effect of the optical isomers of YM-12617 on increased intra-urethral pressure induced by phenylephrine in anaesthetised dogs. J. Auton. Pharmacol. 12: 263-268, 1992.
28. 1-adrenoceptor subtypes in prostate and prostatic urethra of rat, rabbit, dog and man. Eur. J. Pharmacol. 249: 307-315, 1993.
29. 1-antagonist selective for the lower urinary tract: In vivo studies. Neuronal. Urodyn. 13: 471-473, 1994.
30. 1-adrenoceptor antagonist. Pharmacol. Commun. 6: 79-86, 1995.
31. TESTA, R., GUARNERI, L., TADDEI, C., POGGESI, E., ANGELICO, P., SARTANI, A., LEONARDI, A., GOFRIT, O. N., MERETYK, S. AND CAINE, M.: Functional antagonistic activity of rec15/2739, a novel alpha-1 antagonist selective for the lower urinary tract, on noradrenaline-induced contraction of human prostate and mesenteric artery. J. Pharmacol. Exp. Ther. 277: 1237-1246, 1996.
32. 1A-adrenoceptor is not involved in phenylephrine-mediated contractions of rabbit isolated prostate. Eur. Urol. 30/52: 51, 1996.